Nootropic peptides have become a growing focus in cognitive science, stress resilience, and neuroprotective research due to their ability to modulate neurotransmitter activity and support brain function (Dergunova & Filippenkov; Kolomin et al.). Among the most widely studied peptides in this category are Selank and Semax, both of which have demonstrated promising effects on cognition, mood regulation, and neuroplasticity (Volkova et al.; Vyunova et al.).
While both peptides were developed by Russian researchers and share some overlapping benefits, they function through distinct biochemical pathways. Selank primarily influences GABA and serotonin, making it more suited for stress reduction and anxiety regulation (Volkova et al.; Fedorov et al.). Semax, on the other hand, affects dopamine levels and upregulates BDNF, positioning it as a strong candidate in focus, motivation, and neuroprotection research (Dergunova & Filippenkov).
These differences make Selank and Semax valuable in separate but complementary areas of neuroscience and mental health research. This article explores their mechanisms of action, key benefits, and potential research applications, helping researchers understand their unique contributions to cognitive enhancement and stress modulation studies.

